Cargando…

Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens

Previous studies have demonstrated that sera from patients with prostate cancer (PCa) contain autoantibodies that react with tumor-associated antigens (TAAs). Autoantibodies to cyclin B1 and fourteen other TAAs were detected by enzyme-linked immunosorbent assay (ELISA) and Western blotting in 464 se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Liping, Li, Jitian, Ortega, Rosalia, Qian, Wei, Casiano, Carlos A., Zhang, Jian-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016862/ https://www.ncbi.nlm.nih.gov/pubmed/24860838 http://dx.doi.org/10.1155/2014/827827

Ejemplares similares

Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer
por: Li, Jitian, et al.
Publicado: (2016)

A Luminex Approach to Develop an Anti-Tumor-Associated Antigen Autoantibody Panel for the Detection of Prostate Cancer in Racially/Ethnically Diverse Populations
por: Qiu, Cuipeng, et al.
Publicado: (2023)

Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma
por: LIU, MEI, et al.
Publicado: (2015)

Evaluation of Diagnostic Value in Using a Panel of Multiple Tumor-Associated Antigens for Immunodiagnosis of Cancer
por: Wang, Peng, et al.
Publicado: (2014)

Mammalian Genes Preferentially Co-Retained in Radiation Hybrid Panels Tend to Avoid Coexpression
por: Liao, Ben-Yang, et al.
Publicado: (2012)

Identification of Preferentially Expressed Antigen of Melanoma as a Potential Tumor Suppressor in Lung Adenocarcinoma
por: Huang, Quan, et al.
Publicado: (2016)

Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target
por: Almaguel, Frankis A., et al.
Publicado: (2021)

Immunodominant Tuberculosis CD8 Antigens Preferentially Restricted by HLA-B
por: Lewinsohn, Deborah A, et al.
Publicado: (2007)

Tumor-Associated Antigens (TAAs) for the Serological Diagnosis of Osteosarcoma
por: Li, Jitian, et al.
Publicado: (2021)

Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
por: Dai, Liping, et al.
Publicado: (2013)

Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer
por: Dai, Liping, et al.
Publicado: (2017)

A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody‐antigen system
por: Wu, Jinyu, et al.
Publicado: (2021)

Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer
por: Ma, Yan, et al.
Publicado: (2020)

Tumor-associated antigen CAPERα and microvessel density in hepatocellular carcinoma
por: Dai, Liping, et al.
Publicado: (2016)

Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells
por: Kao, Henry, et al.
Publicado: (2001)

DFS70/LEDGFp75: An Enigmatic Autoantigen at the Interface between Autoimmunity, AIDS, and Cancer
por: Basu, Anamika, et al.
Publicado: (2015)

Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis
por: Huang, Quan, et al.
Publicado: (2016)

Cyclin B2 can compensate for Cyclin B1 in oocyte meiosis I
por: Li, Jian, et al.
Publicado: (2018)

Cyclin D1 expression in prostate carcinoma
por: Pereira, R.A., et al.
Publicado: (2014)

Interferon-α promotes neo-antigen formation and preferential HLA-B-restricted antigen presentation in pancreatic β-cells
por: Carré, Alexia, et al.
Publicado: (2023)

Autoimmune-induced preferential depletion of myelin-associated glycoprotein (MAG) is genetically regulated in relapsing EAE (B6 × SJL) F1 mice
por: Skundric, Dusanka S, et al.
Publicado: (2008)

Autoantibodies to Tailor-Made Panels of Tumor-Associated Antigens in Breast Carcinoma
por: Piura, Ettie, et al.
Publicado: (2011)

TSPAN1, TMPRSS4, SDR16C5, and CTSE as Novel Panel for Pancreatic Cancer: A Bioinformatics Analysis and Experiments Validation
por: Ye, Hua, et al.
Publicado: (2021)

Cyclin K and cyclin D1b are oncogenic in myeloma cells
por: Marsaud, Véronique, et al.
Publicado: (2010)

Panel of autoantibodies against multiple tumor‐associated antigens for detecting gastric cancer
por: Hoshino, Isamu, et al.
Publicado: (2017)

Evaluating a Panel of Autoantibodies Against Tumor-Associated Antigens in Human Osteosarcoma
por: Luo, Manli, et al.
Publicado: (2022)

Prognostic role of cyclin B1 in solid tumors: a meta-analysis
por: Ye, Chenyang, et al.
Publicado: (2016)

Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth
por: Ganti, Sheila N., et al.
Publicado: (2015)

Consequence of the tumor-associated conversion to cyclin D1b
por: Augello, Michael A, et al.
Publicado: (2015)

Identification of preferentially exposed crystal facets by X-ray diffraction
por: Zhang, Liping, et al.
Publicado: (2020)

Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells
por: Stathopoulos, Efstathios N, et al.
Publicado: (2003)

A model of preferential pairing between epithelial and dendritic cells in thymic antigen transfer
por: Vobořil, Matouš, et al.
Publicado: (2022)

Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study
por: Cazzato, Gerardo, et al.
Publicado: (2022)

Classification and Antigen Molecules of Autoimmune Bullous Diseases
por: Hashimoto, Takashi, et al.
Publicado: (2023)

African Immigrant Health: Prostate Cancer Attitudes, Perceptions, and Barriers
por: Malika, Nipher, et al.
Publicado: (2020)

A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors
por: Dai, Peng, et al.
Publicado: (2023)

THE PATHOGENESIS OF CHRONIC INFLAMMATION IN EXPERIMENTAL ANTIGEN-INDUCED ARTHRITIS : II. PREFERENTIAL LOCALIZATION OF ANTIGEN-ANTIBODY COMPLEXES TO COLLAGENOUS TISSUES
por: Cooke, T. Derek, et al.
Publicado: (1972)

Concomitant Presence of p16/Cyclin‐dependent Kinase 4 and Cyclin D/Cyclin‐dependent Kinase 4 omplexes in LNCaP Prostatic Cancer Cell Line
por: Itoh, Noriyuki, et al.
Publicado: (1997)

Utilization of Wilms’ tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas
por: Şakirahmet Şen, Dilek, et al.
Publicado: (2016)

MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1
por: Liu, Yunfu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0ubhk3b6nfevor253v6sjvmp4m